Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation
about
Clinical impacts of mesothelin expression in gastrointestinal carcinomasAdvances in liver cancer antibody therapies: a focus on glypican-3 and mesothelinRole of mesothelin in carbon nanotube-induced carcinogenic transformation of human bronchial epithelial cellsMesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cellsA tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.Mesothelin Immunotherapy for Cancer: Ready for Prime Time?Megakaryocytic potentiating factor and mature mesothelin stimulate the growth of a lung cancer cell line in the peritoneal cavity of mice.Inhibition of mesothelin as a novel strategy for targeting cancer cells.Perineural Invasion and TAMs in Pancreatic Ductal Adenocarcinomas: Review of the Original Pathology Reports Using Immunohistochemical Enhancement and Relationships with Clinicopathological Features.Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer.Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms.Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line.Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpressionA novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cellsLuminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancerUnique cellular interactions between pancreatic cancer cells and the omentumPlumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways.The role of mesothelin in tumor progression and targeted therapy.Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathwayIntravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancerBazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma.Translational immunotherapeutics: chemoimmunotherapy for malignant pleural mesothelioma.Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment.The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities.Biomarkers in the prevention and follow-up of workers exposed to asbestos.The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
P2860
Q26748680-29F2E9A5-11AE-4DC7-80AF-07A2FD5AB7C5Q27015134-44991AB9-D9E4-423B-96D0-AD54E0F31428Q27908595-09E6F95D-E914-482F-A4C1-1B47498F2FD4Q29048401-F52CC752-1FFB-46FC-B2A4-148312C5C139Q30571464-EA819220-FB85-4BB2-AB4A-93D9ABE85995Q33688809-1A027477-36EC-427B-886A-C87890AD174FQ33816551-BC4552FB-311B-47D7-B206-530B072702CFQ34042096-C1F9F83C-2699-49F9-831F-98FFADCE1CDFQ34224746-0353FDA2-BD0A-4196-8E93-1CCBCB13730AQ34438719-036CC860-1219-4A36-A85C-4F68E3B2533DQ34774861-9C2F7023-59FE-48B5-A248-C8FD84B7D2DDQ35167481-23659EC6-2225-4FCE-8D41-940229B6921FQ35214050-B265DE82-0387-4CBA-8CE0-B989FE7D01A8Q35219548-BFC88346-1B69-4ED6-B658-CBD6F71690F1Q35323396-8A903E46-97EF-4F52-8FAC-9F5479A55517Q36075289-2C937FAC-0F27-4AC5-9150-22A7A3D2D9CBQ36410426-C721CFED-6C74-44EF-9941-C0B3F7BBAF8FQ36466176-EA2E83AD-088F-4789-8FC4-1208A4E75444Q36597831-6BEAED37-EFBD-4D95-8D5F-935794B00ABBQ36649265-8F907C0F-2576-458E-836C-A5665FC3F453Q36857863-CF524F8C-0F31-4F1C-8245-7D272569863CQ38734014-70AD6263-4055-40B3-B900-DBC399544F56Q39178281-9CC87D93-DE5C-4152-BE98-98DFF3360D47Q42563176-1ED159E3-CA5A-4E54-8FE7-52AFB4019FDDQ47107902-72C4B9A9-D27E-45E6-B95D-3CEC74E574FFQ47309343-8ADDC2EF-1BBF-4225-9264-D564FC71ED9EQ48098689-1E81B695-2B2D-4DD5-96C4-6A3501CC5ADEQ52672882-E841D2C3-A160-4AAF-B1B2-F5A0682B5DF4Q58726271-1219F941-A4BB-41A9-8F48-177EFE275C11
P2860
Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mesothelin overexpression prom ...... atic cancer cell proliferation
@ast
Mesothelin overexpression prom ...... atic cancer cell proliferation
@en
type
label
Mesothelin overexpression prom ...... atic cancer cell proliferation
@ast
Mesothelin overexpression prom ...... atic cancer cell proliferation
@en
prefLabel
Mesothelin overexpression prom ...... atic cancer cell proliferation
@ast
Mesothelin overexpression prom ...... atic cancer cell proliferation
@en
P2093
P2860
P356
P1433
P1476
Mesothelin overexpression prom ...... atic cancer cell proliferation
@en
P2093
Changyi Chen
Christian Marin-Muller
Uddalak Bharadwaj
P2860
P304
P356
10.1093/CARCIN/BGR075
P407
P577
2011-04-23T00:00:00Z